NEW YORK, Dec. 20, 2021 /PRNewswire/ -- The cell surface markers market is driven by the COVID-19 pandemic impact. The market size is expected to increase by USD 10.00 bn from 2021 to 2026. However, the growth momentum of the market will decelerate at a CAGR of 7.40%.
For more valuable insights into the cell surface markers market, View Our Free Sample Now
Market Dynamics
The COVID-19 pandemic impact is driving the growth of the cell surfers markers market. Cell surface markers are carbohydrates and proteins attached to the cell membrane and play a key role in intercellular signaling. Many research projects involve the interaction of COVID-19 antibodies with cell surface markers. Secondary fungal infections are becoming common in COVID-19 patients as their immunity reduces. As a result, the use of cell surface markers to research fungal infection is predicted to increase. Such activities contribute to a greater understanding of the condition, which leads to novel approaches to finding a cure.
The cell surface markers market will be challenged by the high investment in instruments during the forecast period. Firms need to invest heavily in instruments and models to carry out research in cell surface markers. This limits the entry of start-ups and small-scale industries into the cell surface marker market. Many clinical laboratories are reluctant to invest in sophisticated cell marker analysis instruments owing to the complexity and high cost of instruments and the uncertainty surrounding the regulation and reimbursement for cell marker diagnostic tests. Small pharmaceutical companies do not prefer to invest in high-tech flow cytometers and hematology analyzers due to unclear cost-benefit ratios. Drug development is expensive, and small pharmaceutical firms cannot afford to purchase expensive equipment and supplies. This, in turn, limits the growth of the market for cell surface markers.
Do you want to know more about the drivers and challenges and their impact on the market? View Our Free Sample
Company Profiles
The cell surface markers market report provides complete insights on key vendors, including Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Grifols SA, QIAGEN NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.
Competitive Analysis
The report includes the competitive analysis, a proprietary tool to analyze and evaluate the position of companies based on their industry position score and market performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Market Segmentation
Subscribe to our "Lite Plan" billed annually at USD 3000 that enables you to download 3 reports a year and view 3 reports every month.
Related Reports
Cell Surface Markers Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Decelerate at a CAGR of 7.40% |
Market growth 2022-2026 |
USD 10.00 billion |
Market structure |
Fragmented |
YoY growth (%) |
9.96 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 37% |
Key consumer countries |
US, China, UK, Germany, and France |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Grifols SA, QIAGEN NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period, |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article